• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于强度区域的多分类器方案,用于提高蛋白质组 MS 谱的分类准确性。

An intensity-region driven multi-classifier scheme for improving the classification accuracy of proteomic MS-spectra.

机构信息

Department of Medical Physics, University of Patras, Rio, Greece.

出版信息

Comput Methods Programs Biomed. 2010 Aug;99(2):147-53. doi: 10.1016/j.cmpb.2009.11.003. Epub 2009 Dec 9.

DOI:10.1016/j.cmpb.2009.11.003
PMID:20004492
Abstract

In this study, a pattern recognition system is presented for improving the classification accuracy of MS-spectra by means of gathering information from different MS-spectra intensity regions using a majority vote ensemble combination. The method starts by automatically breaking down all MS-spectra into common intensity regions. Subsequently, the most informative features (m/z values), which might constitute potential significant biomarkers, are extracted from each common intensity region over all the MS-spectra and, finally, normal from ovarian cancer MS-spectra are discriminated using a multi-classifier scheme, with members the Support Vector Machine, the Probabilistic Neural Network and the k-Nearest Neighbour classifiers. Clinical material was obtained from the publicly available ovarian proteomic dataset (8-7-02). To ensure robust and reliable estimates, the proposed pattern recognition system was evaluated using an external cross-validation process. The average overall performance of the system in discriminating normal from cancer ovarian MS-spectra was 97.18% with 98.52% mean sensitivity and 94.84% mean specificity values.

摘要

在这项研究中,提出了一种模式识别系统,通过使用多数投票集成组合从不同的 MS 光谱强度区域收集信息,从而提高 MS 光谱的分类准确性。该方法首先自动将所有 MS 光谱分解为常见的强度区域。随后,从所有 MS 光谱的每个常见强度区域中提取最具信息量的特征(m/z 值),这些特征可能构成潜在的显著生物标志物,最后使用多分类器方案(支持向量机、概率神经网络和 k 最近邻分类器)对正常和卵巢癌 MS 光谱进行区分。临床材料取自公开的卵巢蛋白质组数据集(8-7-02)。为了确保稳健和可靠的估计,使用外部交叉验证过程评估了所提出的模式识别系统。该系统在区分正常和癌症卵巢 MS 光谱方面的平均整体性能为 97.18%,平均灵敏度为 98.52%,平均特异性为 94.84%。

相似文献

1
An intensity-region driven multi-classifier scheme for improving the classification accuracy of proteomic MS-spectra.一种基于强度区域的多分类器方案,用于提高蛋白质组 MS 谱的分类准确性。
Comput Methods Programs Biomed. 2010 Aug;99(2):147-53. doi: 10.1016/j.cmpb.2009.11.003. Epub 2009 Dec 9.
2
Data mining techniques for cancer detection using serum proteomic profiling.利用血清蛋白质组分析进行癌症检测的数据挖掘技术
Artif Intell Med. 2004 Oct;32(2):71-83. doi: 10.1016/j.artmed.2004.03.006.
3
Machine learning methods for predictive proteomics.用于预测蛋白质组学的机器学习方法。
Brief Bioinform. 2008 Mar;9(2):119-28. doi: 10.1093/bib/bbn008. Epub 2008 Feb 29.
4
Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.基于极高维变量的两组对比的同时精确区间估计:在质谱数据中的应用
Bioinformatics. 2007 Jun 15;23(12):1451-8. doi: 10.1093/bioinformatics/btm130. Epub 2007 Apr 25.
5
Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.用于卵巢癌检测的质谱蛋白质组学的判别分析
Acta Pharmacol Sin. 2008 Oct;29(10):1240-6. doi: 10.1111/j.1745-7254.2008.00861.x.
6
Quantitative Proteome-Property Relationships (QPPRs). Part 1: finding biomarkers of organic drugs with mean Markov connectivity indices of spiral networks of blood mass spectra.定量蛋白质组-性质关系(QPPRs)。第1部分:利用血质谱螺旋网络的平均马尔可夫连通性指数寻找有机药物的生物标志物。
Bioorg Med Chem. 2008 Nov 15;16(22):9684-93. doi: 10.1016/j.bmc.2008.10.004. Epub 2008 Oct 5.
7
Classification of peptide mass fingerprint data by novel no-regret boosting method.采用新型无悔增强法对肽质量指纹数据进行分类。
Comput Biol Med. 2009 May;39(5):460-73. doi: 10.1016/j.compbiomed.2009.03.006. Epub 2009 Apr 21.
8
Proteomic studies of early-stage and advanced ovarian cancer patients.早期和晚期卵巢癌患者的蛋白质组学研究。
Gynecol Oncol. 2008 Oct;111(1):111-9. doi: 10.1016/j.ygyno.2008.06.031. Epub 2008 Aug 15.
9
A cross-validation study to select a classification procedure for clinical diagnosis based on proteomic mass spectrometry.一项基于蛋白质组质谱法选择用于临床诊断的分类程序的交叉验证研究。
Stat Appl Genet Mol Biol. 2008;7(2):Article12. doi: 10.2202/1544-6115.1363. Epub 2008 Mar 24.
10
Mixture classification model based on clinical markers for breast cancer prognosis.基于临床标志物的乳腺癌预后混合分类模型。
Artif Intell Med. 2010 Feb-Mar;48(2-3):129-37. doi: 10.1016/j.artmed.2009.07.008. Epub 2009 Dec 14.